Net Cash Provided by (Used in) Operating Activities in USD of ORAMED PHARMACEUTICALS INC. from Q4 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Oramed Pharmaceuticals Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q4 2010 to Q1 2025.
  • Oramed Pharmaceuticals Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2025 was -$3.52M, a 138% decline year-over-year.
  • Oramed Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$8.41M, a 18.3% increase from 2023.
  • Oramed Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$10.3M, a 63.1% increase from 2022.
  • Oramed Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$27.9M, a 31.8% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)

ORAMED PHARMACEUTICALS INC. Quarterly Net Cash Provided by (Used in) Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$3.52M -$2.04M -138% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-15
Q1 2024 -$1.48M +$4.07M +73.4% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-15
Q1 2023 -$5.55M +$3.58M +39.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 -$9.13M -$5.44M -148% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$11.1M -$2.86M -34.6% Sep 1, 2021 Dec 31, 2021 10-K 2023-03-06
Q1 2021 -$3.68M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$8.26M -$5.27M -176% Sep 1, 2020 Dec 31, 2020 10-QT 2022-03-30
Q4 2019 -$3M +$1.14M +27.5% Sep 1, 2019 Nov 30, 2019 10-Q 2021-01-14
Q4 2018 -$4.13M -$1.4M -51.4% Sep 1, 2018 Nov 30, 2018 10-Q 2020-01-09
Q4 2017 -$2.73M -$4.23M -282% Sep 1, 2017 Nov 30, 2017 10-Q 2019-01-14
Q4 2016 $1.5M +$3.75M Sep 1, 2016 Nov 30, 2016 10-Q 2018-01-11
Q4 2015 -$2.25M -$848K -60.6% Sep 1, 2015 Nov 30, 2015 10-Q 2017-01-11
Q4 2014 -$1.4M -$651K -87% Sep 1, 2014 Nov 30, 2014 10-Q 2016-01-13
Q4 2013 -$748K +$44.8K +5.65% Sep 1, 2013 Nov 30, 2013 10-Q 2015-01-08
Q4 2012 -$793K -$309K -63.8% Sep 1, 2012 Nov 30, 2012 10-Q 2014-01-14
Q4 2011 -$484K +$14.3K +2.87% Sep 1, 2011 Nov 30, 2011 10-Q 2012-12-26
Q4 2010 -$498K Sep 1, 2010 Nov 30, 2010 10-Q 2012-01-12

ORAMED PHARMACEUTICALS INC. Annual Net Cash Provided by (Used in) Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$8.41M +$1.88M +18.3% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-27
2023 -$10.3M +$17.6M +63.1% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-27
2022 -$27.9M -$6.74M -31.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-06
2021 -$21.2M -$8.74M -70.3% Sep 1, 2020 Aug 31, 2021 10-K 2023-03-06
2020 -$12.4M +$500K +3.86% Sep 1, 2019 Aug 31, 2020 10-K 2021-11-24
2019 -$12.9M +$1.72M +11.7% Sep 1, 2018 Aug 31, 2019 10-K 2020-11-24
2018 -$14.7M -$8.83M -151% Sep 1, 2017 Aug 31, 2018 10-K 2019-11-27
2017 -$5.83M -$10.5M -225% Sep 1, 2016 Aug 31, 2017 10-K 2019-11-27
2016 $4.66M +$9.6M Sep 1, 2015 Aug 31, 2016 10-K 2018-11-28
2015 -$4.95M -$878K -21.6% Sep 1, 2014 Aug 31, 2015 10-K 2017-11-29
2014 -$4.07M -$672K -19.8% Sep 1, 2013 Aug 31, 2014 10-K 2016-11-25
2013 -$3.4M -$1.1M -47.6% Sep 1, 2012 Aug 31, 2013 10-K 2015-11-25
2012 -$2.3M -$595K -34.9% Sep 1, 2011 Aug 31, 2012 10-K 2014-11-14
2011 -$1.71M Sep 1, 2010 Aug 31, 2011 10-K 2012-12-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.